311 related articles for article (PubMed ID: 15644871)
1. Pharmacodynamics and pharmacokinetics of SQ109, a new diamine-based antitubercular drug.
Jia L; Tomaszewski JE; Hanrahan C; Coward L; Noker P; Gorman G; Nikonenko B; Protopopova M
Br J Pharmacol; 2005 Jan; 144(1):80-7. PubMed ID: 15644871
[TBL] [Abstract][Full Text] [Related]
2. Pharmacoproteomic effects of isoniazid, ethambutol, and N-geranyl-N'-(2-adamantyl)ethane-1,2-diamine (SQ109) on Mycobacterium tuberculosis H37Rv.
Jia L; Coward L; Gorman GS; Noker PE; Tomaszewski JE
J Pharmacol Exp Ther; 2005 Nov; 315(2):905-11. PubMed ID: 16085758
[TBL] [Abstract][Full Text] [Related]
3. Simultaneous estimation of pharmacokinetic properties in mice of three anti-tubercular ethambutol analogs obtained from combinatorial lead optimization.
Jia L; Tomaszewski JE; Noker PE; Gorman GS; Glaze E; Protopopova M
J Pharm Biomed Anal; 2005 Apr; 37(4):793-9. PubMed ID: 15797803
[TBL] [Abstract][Full Text] [Related]
4. Identification of a new antitubercular drug candidate, SQ109, from a combinatorial library of 1,2-ethylenediamines.
Protopopova M; Hanrahan C; Nikonenko B; Samala R; Chen P; Gearhart J; Einck L; Nacy CA
J Antimicrob Chemother; 2005 Nov; 56(5):968-74. PubMed ID: 16172107
[TBL] [Abstract][Full Text] [Related]
5. Isoniazid pharmacokinetics-pharmacodynamics in an aerosol infection model of tuberculosis.
Jayaram R; Shandil RK; Gaonkar S; Kaur P; Suresh BL; Mahesh BN; Jayashree R; Nandi V; Bharath S; Kantharaj E; Balasubramanian V
Antimicrob Agents Chemother; 2004 Aug; 48(8):2951-7. PubMed ID: 15273105
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetic and pharmacodynamic behaviour of antitubercular drugs encapsulated in alginate nanoparticles at two doses.
Ahmad Z; Pandey R; Sharma S; Khuller GK
Int J Antimicrob Agents; 2006 May; 27(5):409-16. PubMed ID: 16624533
[TBL] [Abstract][Full Text] [Related]
7. Novel, potent, orally bioavailable and selective mycobacterial ATP synthase inhibitors that demonstrated activity against both replicating and non-replicating M. tuberculosis.
Singh S; Roy KK; Khan SR; Kashyap VK; Sharma A; Jaiswal S; Sharma SK; Krishnan MY; Chaturvedi V; Lal J; Sinha S; Dasgupta A; Srivastava R; Saxena AK
Bioorg Med Chem; 2015 Feb; 23(4):742-52. PubMed ID: 25614114
[TBL] [Abstract][Full Text] [Related]
8. Synergistic interactions of SQ109, a new ethylene diamine, with front-line antitubercular drugs in vitro.
Chen P; Gearhart J; Protopopova M; Einck L; Nacy CA
J Antimicrob Chemother; 2006 Aug; 58(2):332-7. PubMed ID: 16751637
[TBL] [Abstract][Full Text] [Related]
9. Subcutaneous nanoparticle-based antitubercular chemotherapy in an experimental model.
Pandey R; Khuller GK
J Antimicrob Chemother; 2004 Jul; 54(1):266-8. PubMed ID: 15128731
[TBL] [Abstract][Full Text] [Related]
10. Design and synthesis of antituberculars: preparation and evaluation against Mycobacterium tuberculosis of an isoniazid Schiff base.
Hearn MJ; Cynamon MH
J Antimicrob Chemother; 2004 Feb; 53(2):185-91. PubMed ID: 14688045
[TBL] [Abstract][Full Text] [Related]
11. SQ109 and PNU-100480 interact to kill Mycobacterium tuberculosis in vitro.
Reddy VM; Dubuisson T; Einck L; Wallis RS; Jakubiec W; Ladukto L; Campbell S; Nacy CA
J Antimicrob Chemother; 2012 May; 67(5):1163-6. PubMed ID: 22258923
[TBL] [Abstract][Full Text] [Related]
12. Ethambutol in paediatric tuberculosis: aspects of ethambutol serum concentration, efficacy and toxicity in children.
Thee S; Detjen A; Quarcoo D; Wahn U; Magdorf K
Int J Tuberc Lung Dis; 2007 Sep; 11(9):965-71. PubMed ID: 17705973
[TBL] [Abstract][Full Text] [Related]
13. Lectin-functionalized poly (lactide-co-glycolide) nanoparticles as oral/aerosolized antitubercular drug carriers for treatment of tuberculosis.
Sharma A; Sharma S; Khuller GK
J Antimicrob Chemother; 2004 Oct; 54(4):761-6. PubMed ID: 15329364
[TBL] [Abstract][Full Text] [Related]
14. Population pharmacokinetics of isoniazid in the treatment of Mycobacterium tuberculosis among Asian and African elephants (Elephas maximus and Loxodonta africana).
Maslow JN; Mikota SK; Zhu M; Isaza R; Peddie LR; Dunker F; Peddie J; Riddle H; Peloquin CA
J Vet Pharmacol Ther; 2005 Feb; 28(1):21-7. PubMed ID: 15720511
[TBL] [Abstract][Full Text] [Related]
15. Chemotherapy of tuberculosis in mice using single implants of isoniazid and pyrazinamide.
Gangadharam PR; Geeta N; Hsu YY; Wise DL
Int J Tuberc Lung Dis; 1999 Jun; 3(6):515-20. PubMed ID: 10383065
[TBL] [Abstract][Full Text] [Related]
16. Inhalable microparticles of nitric oxide donors induce phagosome maturation and kill Mycobacterium tuberculosis.
Verma RK; Agrawal AK; Singh AK; Mohan M; Gupta A; Gupta P; Gupta UD; Misra A
Tuberculosis (Edinb); 2013 Jul; 93(4):412-7. PubMed ID: 23562366
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics of antituberculosis drugs after oral isolated and simultaneous administration in triple combination.
Zítková L; Janků I; Tousek J; Papezová E; Stastná J
Czech Med; 1983; 6(4):202-17. PubMed ID: 6420125
[TBL] [Abstract][Full Text] [Related]
18. Pharmaceutical formulation of a fixed-dose anti-tuberculosis combination.
Danckwerts MP; Ebrahim S; Pillay V
Int J Tuberc Lung Dis; 2003 Mar; 7(3):289-97. PubMed ID: 12661846
[TBL] [Abstract][Full Text] [Related]
19. Drug therapy of experimental tuberculosis (TB): improved outcome by combining SQ109, a new diamine antibiotic, with existing TB drugs.
Nikonenko BV; Protopopova M; Samala R; Einck L; Nacy CA
Antimicrob Agents Chemother; 2007 Apr; 51(4):1563-5. PubMed ID: 17242141
[TBL] [Abstract][Full Text] [Related]
20. Targeted drug delivery to enhance efficacy and shorten treatment duration in disseminated Mycobacterium avium infection in mice.
de Steenwinkel JE; van Vianen W; Ten Kate MT; Verbrugh HA; van Agtmael MA; Schiffelers RM; Bakker-Woudenberg IA
J Antimicrob Chemother; 2007 Nov; 60(5):1064-73. PubMed ID: 17846106
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
